PDCD1 and cancer: In conclusion, our findings indicate that MSC-derived exosomal miR-125b-5p enhances the efficacy of anti-PD-1 therapy in cancer treatment, thereby providing robust evidence for the translational research of miRNAs in future therapeutic strategies.